ANIK CapEx to Revenue

Anika Therapeutics Inc · CapEx to Revenue

ANIK logo

ANIK CapEx to Revenue

Current (TTM)4.49%
ANIK CapEx/Revenue (63.64% → 4.49%)
High-resolution chart · PNG

ANIK capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
6.0504%
6.45%
4.4928%
6.5766%
3.4798%
1.2479%
2.4666%
4.411%
7.9175%
13.5559%
9.9195%
1.4706%
0.5872%
2.1087%
2.1617%
5.0129%
9.8721%
45.4069%
47.8611%
4.865%
5.3628%
1.791%
1.6619%
0.6743%
8.031%
3.0936%
12.5926%
15.8273%
2.5%
0%
8.8235%
4.2553%
63.6364%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.